Revilmeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,653 | 9,256 | 293 | 765 | 1,125 | 3,205 | 7,700 | 13,360 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -9,175 | -7,416 | -14,103 | -9,730 | -10,178 | -8,630 | -6,142 | -3,519 |
| Equity | 57,019 | 49,603 | 35,500 | 25,770 | 15,592 | 6,962 | 820 | -2,699 |
| Liabilities | 685 | 703 | 657 | 7 | 550 | 269 | 3,766 | 3,864 |
| Non-current assets | 0 | 0 | 7,589 | 6,743 | 5,896 | 5,049 | 4,203 | 0 |
| Current assets | 57,704 | 50,306 | 28,568 | 18,965 | 10,246 | 2,182 | 383 | 1,165 |
| Total assets | 57,704 | 50,306 | 36,157 | 25,708 | 16,142 | 7,231 | 4,586 | 1,165 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 505 | 462 | 729 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -88.9% | +153.4% | -96.8% | +161.1% | +47.1% | +184.9% | +140.2% | +73.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -15.9% | -14.7% | -39.0% | -37.8% | -63.1% | -119.3% | -133.9% | -302.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -16.1% | -15.0% | -39.7% | -37.8% | -65.3% | -124.0% | -749.0% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -251.2% | -80.1% | -4813.3% | -1271.9% | -904.7% | -269.3% | -79.8% | -26.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.6 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,827 | 4,628 | 220 | 765 | 1,125 | 3,205 | 7,700 | 13,360 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Revilmeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-05-18 | 279.84 |
| 2026-03-27 | 2026-03-27 | 279.84 |
| 2026-03-17 | 2026-03-18 | 279.84 |
| 2026-01-16 | 2026-01-18 | 251.92 |
| 2025-12-16 | 2025-12-16 | 251.92 |
| 2024-07-16 | 2024-07-17 | 224.25 |
| 2024-05-16 | 2024-05-19 | 224.25 |
| 2024-04-16 | 2024-04-18 | 224.25 |
| 2024-02-19 | 2024-02-19 | 224.25 |
| 2024-01-16 | 2024-01-16 | 203.87 |
| 2023-08-17 | 2023-08-17 | 203.87 |
| 2022-01-18 | 2022-02-14 | 0.89 |
| 2021-12-16 | 2021-12-19 | 1.23 |
| 2021-11-16 | 2021-12-13 | 0.34 |
Revilmeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-07-16 | 2026-08-06 | 3.58 |
| 2026-03-11 | 2026-07-15 | 1.0 |
| 2024-06-30 | 2025-05-20 | 3.43 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.